SCHEMBL3200145

SCHEMBL3200145

COc1ccc(N(Cc2cnccn2)c2ccc(C(=O)OC(C)(C)C)cc2)cc1OC(F)F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.37
SLC5A7 Q9GZV3 1/20 0.36
KMT2A Q03164 2/20 0.36
HDAC6 Q9UBN7 1/20 0.36
GAA P10253 3/20 0.36
FGFR1 P11362 1/20 0.36
FGFR2 P21802 1/20 0.36
FGFR4 P22455 1/20 0.36
FGFR3 P22607 1/20 0.36
KDR P35968 1/20 0.36
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KLK3 P07288 1/20 0.34
HPGDS O60760 1/20 0.34
PDE4B Q07343 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
BUB1 O43683 1/20 0.33
KDM4E B2RXH2 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3193436 0.96 SYK (0.37) SYKSLC5A7KMT2AHDAC6GAA
SCHEMBL3131342 0.95 HDAC6 (0.37) SYKKMT2AHDAC6GAAFGFR1
SCHEMBL3129505 0.92 RXRA (0.38) SYKKMT2AHDAC6GAAFGFR1
SCHEMBL3215299 0.90 HDAC6 (0.37) SYKKMT2AHDAC6GAARAB9A
SCHEMBL3132346 0.88 SYK (0.40) SYKSLC5A7KMT2AGAAFGFR1
SCHEMBL3132792 0.88 KMT2A (0.36) KMT2AHDAC6GAAFGFR1FGFR2
SCHEMBL3130954 0.87 PDE4B (0.48) PDE4BPDE4APDE4CPDE4D
SCHEMBL3129434 0.85 KMT2A (0.37) SYKSLC5A7KMT2AGAAFGFR1
SCHEMBL3215279 0.85 RXRA (0.35) KMT2AHDAC6GAARAB9ASMN1; SMN2
SCHEMBL3122655 0.84 SYK (0.40) SYKSLC5A7KMT2AGAAFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B SYK 2747/4885SLC5A7 1884/4885KMT2A 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.